Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soussi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soussi, T.
[Cancer Research 60, 1777-1788, April 1, 2000]
© 2000 American Association for Cancer Research

Review

p53 Antibodies in the Sera of Patients with Various Types of Cancer: A Review1

Thierry Soussi2

Laboratoire de génotoxicologie des tumeurs, Institut Curie, 75248 Paris, France

p53 antibodies (p53-Abs) were discovered 20 years ago during the course of tumor-associated antigens screening. The discovery of p53 mutation and accumulation of p53 in human tumors shed new light on the p53 humoral response. In the present review, we have compiled more than 130 papers published in this specific field since 1992. We demonstrate that p53-Abs are found predominantly in human cancer patients with a specificity of 96%. Such antibodies are predominantly associated with p53 gene missense mutations and p53 accumulation in the tumor, but the sensitivity of such detection is only 30%. It has been demonstrated that this immune response is due to a self-immunization process linked to the strong immunogenicity of the p53 protein. The clinical value of these antibodies remains subject to debate, but consistent results have been observed in breast, colon, oral, and gastric cancers, in which they have been associated with high-grade tumors and poor survival. The finding of p53-Abs in the sera of individuals who are at high risk of cancer, such as exposed workers or heavy smokers, indicates that they have promising potential in the early detection of cancer.




This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
B. S. Taylor, M. Pal, J. Yu, B. Laxman, S. Kalyana-Sundaram, R. Zhao, A. Menon, J. T. Wei, A. I. Nesvizhskii, D. Ghosh, et al.
Humoral Response Profiling Reveals Pathways to Prostate Cancer Progression
Mol. Cell. Proteomics, March 1, 2008; 7(3): 600 - 611.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. M. Lauwen, S. Zwaveling, L. de Quartel, S. C. Ferreira Mota, J. A.C. Grashorn, C. J.M. Melief, S. H. van der Burg, and R. Offringa
Self-Tolerance Does Not Restrict the CD4+ T-Helper Response against the p53 Tumor Antigen
Cancer Res., February 1, 2008; 68(3): 893 - 900.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Gagnon, J.-H. Kim, J. O. Schorge, B. Ye, B. Liu, K. Hasselblatt, W. R. Welch, C. A. Bandera, and S. C. Mok
Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients
Clin. Cancer Res., February 1, 2008; 14(3): 764 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. R. Pereira-Faca, R. Kuick, E. Puravs, Q. Zhang, A. L. Krasnoselsky, D. Phanstiel, J. Qiu, D. E. Misek, R. Hinderer, M. Tammemagi, et al.
Identification of 14-3-3{theta} as an Antigen that Induces a Humoral Response in Lung Cancer
Cancer Res., December 15, 2007; 67(24): 12000 - 12006.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H.-S. Lin, H. S. Talwar, A. L. Tarca, A. Ionan, M. Chatterjee, B. Ye, J. Wojciechowski, S. Mohapatra, M. D. Basson, G. H. Yoo, et al.
Autoantibody Approach for Serum-Based Detection of Head and Neck Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2396 - 2405.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. E. Hudson, I. Pozdnyakova, K. Haines, G. Mor, and M. Snyder
Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays
PNAS, October 30, 2007; 104(44): 17494 - 17499.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
P. Das, K. Vaiphei, D. Jain, and Jai Dev Wig
p53 and mdm2 Expression in Colorectal Carcinoma: A Correlative Analysis With Clinical Staging and Histological Parameters
International Journal of Surgical Pathology, October 1, 2007; 15(4): 335 - 345.
[Abstract] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
M. Caron, G. Choquet-Kastylevsky, and R. Joubert-Caron
Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery
Mol. Cell. Proteomics, July 1, 2007; 6(7): 1115 - 1122.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. Gasser, C. Gerstlauer, M. Grimm, M. Bueter, T. Lebedeva, J. Lutz, U. Maeder, C. Ribas, C. Ribas, E. Nichiporuk, et al.
Comparative Analysis of Predictive Biomarkers for Therapeutical Strategies in Colorectal Cancer
Ann. Surg. Oncol., April 1, 2007; 14(4): 1272 - 1284.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Chen, X. Wang, J. Yu, S. Varambally, J. Yu, D. G. Thomas, M.-Y. Lin, P. Vishnu, Z. Wang, R. Wang, et al.
Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma
Cancer Res., April 1, 2007; 67(7): 3461 - 3467.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. J. Nesslinger, R. A. Sahota, B. Stone, K. Johnson, N. Chima, C. King, D. Rasmussen, D. Bishop, P. S. Rennie, M. Gleave, et al.
Standard Treatments Induce Antigen-Specific Immune Responses in Prostate Cancer
Clin. Cancer Res., March 1, 2007; 13(5): 1493 - 1502.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Ito, A. Albers, Y. X. Zhao, C. Visus, E. Appella, T. L. Whiteside, and A. B. DeLeo
The Wild-Type Sequence (wt) p5325-35 Peptide Induces HLA-DR7 and HLA-DR11-Restricted CD4+ Th Cells Capable of Enhancing the Ex Vivo Expansion and Function of Anti-wt p53264-272 Peptide CD8+ T Cells
J. Immunol., November 15, 2006; 177(10): 6795 - 6803.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Fujita, T. Nakanishi, M. Hiramatsu, H. Mabuchi, Y. Miyamoto, A. Miyamoto, A. Shimizu, and N. Tanigawa
Proteomics-Based Approach Identifying Autoantibody against Peroxiredoxin VI as a Novel Serum Marker in Esophageal Squamous Cell Carcinoma.
Clin. Cancer Res., November 1, 2006; 12(21): 6415 - 6420.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
C. A. Casiano, M. Mediavilla-Varela, and E. M. Tan
Tumor-associated Antigen Arrays for the Serological Diagnosis of Cancer
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1745 - 1759.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Robin, J. Andreu-Gallien, M.-H. Schlageter, D. Bengoufa, I. Guillemot, K. Pokorna, C. Robert, J. Larghero, P. Rousselot, E. Raffoux, et al.
Frequent antibody production against RAR{alpha} in both APL mice and patients
Blood, September 15, 2006; 108(6): 1972 - 1974.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
V. Goodell, L. G. Salazar, N. Urban, C. W. Drescher, H. Gray, R. E. Swensen, M. W. McIntosh, and M. L. Disis
Antibody Immunity to the p53 Oncogenic Protein Is a Prognostic Indicator in Ovarian Cancer
J. Clin. Oncol., February 10, 2006; 24(5): 762 - 768.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Erkanli, D. D. Taylor, D. Dean, F. Eksir, D. Egger, J. Geyer, B. H. Nelson, B. Stone, H. A. Fritsche, and R. B.S. Roden
Application of Bayesian Modeling of Autologous Antibody Responses against Ovarian Tumor-Associated Antigens to Cancer Detection
Cancer Res., February 1, 2006; 66(3): 1792 - 1798.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
X. Wang, J. Yu, A. Sreekumar, S. Varambally, R. Shen, D. Giacherio, R. Mehra, J. E. Montie, K. J. Pienta, M. G. Sanda, et al.
Autoantibody Signatures in Prostate Cancer
N. Engl. J. Med., September 22, 2005; 353(12): 1224 - 1235.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Fernandez-Madrid, N. Tang, H. Alansari, J. L. Granda, L. Tait, K. C. Amirikia, M. Moroianu, X. Wang, and R. L. Karvonen
Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer
Cancer Res., August 1, 2004; 64(15): 5089 - 5096.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. T. Chang, F.-H. Wong, C.-T. Liao, I-H. Chen, H.-M. Wang, and A.-J. Cheng
Enzyme Immunoassay for Serum Autoantibody to Survivin and Its Findings in Head-and-Neck Cancer Patients
Clin. Chem., July 1, 2004; 50(7): 1261 - 1264.
[Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
H. H. SCHLECHTE, C. STELZER, S. WEICKMANN, M. FLEISCHHACKER, and G. SCHULZE
TP53 Gene in Blood Plasma DNA of Tumor Patients
Ann. N.Y. Acad. Sci., June 1, 2004; 1022(1): 61 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. A. Koziol, J.-Y. Zhang, C. A. Casiano, X.-X. Peng, F.-D. Shi, A. C. Feng, E. K. L. Chan, and E. M. Tan
Recursive Partitioning as an Approach to Selection of Immune Markers for Tumor Diagnosis
Clin. Cancer Res., November 1, 2003; 9(14): 5120 - 5126.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Chikamatsu, A. Albers, J. Stanson, W. W. Kwok, E. Appella, T. L. Whiteside, and A. B. DeLeo
p53110-124-specific Human CD4+ T-helper Cells Enhance in Vitro Generation and Antitumor Function of Tumor-reactive CD8+ T Cells
Cancer Res., July 1, 2003; 63(13): 3675 - 3681.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J.-Y. Zhang, C. A. Casiano, X.-X. Peng, J. A. Koziol, E. K. L. Chan, and E. M. Tan
Enhancement of Antibody Detection in Cancer Using Panel of Recombinant Tumor-associated Antigens
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 136 - 143.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. H. Hansen, H. V. Nielsen, and H. J. Ditzel
Translocation of an Intracellular Antigen to the Surface of Medullary Breast Cancer Cells Early in Apoptosis Allows for an Antigen-Driven Antibody Response Elicited by Tumor-Infiltrating B Cells
J. Immunol., September 1, 2002; 169(5): 2701 - 2711.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. J. Scanlan, S. Welt, C. M. Gordon, Y.-T. Chen, A. O. Gure, E. Stockert, A. A. Jungbluth, G. Ritter, D. Jager, E. Jager, et al.
Cancer-related Serological Recognition of Human Colon Cancer: Identification of Potential Diagnostic and Immunotherapeutic Targets
Cancer Res., July 15, 2002; 62(14): 4041 - 4047.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. H. van der Burg, A. G Menon, A. Redeker, M.-C. Bonnet, J. W. Drijfhout, R. A. E. M. Tollenaar, C. J. H. van de Velde, P. Moingeon, P. J. K. Kuppen, R. Offringa, et al.
Induction of p53-specific Immune Responses in Colorectal Cancer Patients Receiving a Recombinant ALVAC-p53 Candidate Vaccine
Clin. Cancer Res., May 1, 2002; 8(5): 1019 - 1027.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
O. A. Elisseeva, Y. Oka, A. Tsuboi, K. Ogata, F. Wu, E. H. Kim, T. Soma, H. Tamaki, M. Kawakami, Y. Oji, et al.
Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies
Blood, May 1, 2002; 99(9): 3272 - 3279.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
F. Le Naour, F. Brichory, D. E. Misek, C. Brechot, S. M. Hanash, and L. Beretta
A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis
Mol. Cell. Proteomics, March 1, 2002; 1(3): 197 - 203.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Brichory, D. Beer, F. LeNaour, T. Giordano, and S. Hanash
Proteomics-based Identification of Protein Gene Product 9.5 as a Tumor Antigen That Induces a Humoral Immune Response in Lung Cancer
Cancer Res., November 1, 2001; 61(21): 7908 - 7912.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Le Naour, D. E. Misek, M. C. Krause, L. Deneux, T. J. Giordano, S. Scholl, and S. M. Hanash
Proteomics-based Identification of RS/DJ-1 as a Novel Circulating Tumor Antigen in Breast Cancer
Clin. Cancer Res., November 1, 2001; 7(11): 3328 - 3335.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Lu, R. M. Nakamura, E. D. Dent, J.-Y. Zhang, F. C. Nielsen, J. Christiansen, E. K. L. Chan, and E. M. Tan
Aberrant Expression of Fetal RNA-Binding Protein p62 in Liver Cancer and Liver Cirrhosis
Am. J. Pathol., September 1, 2001; 159(3): 945 - 953.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. M. Brichory, D. E. Misek, A.-M. Yim, M. C. Krause, T. J. Giordano, D. G. Beer, and S. M. Hanash
An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer
PNAS, August 14, 2001; 98(17): 9824 - 9829.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
M Abu-Shakra, D Buskila, M Ehrenfeld, K Conrad, and Y Shoenfeld
Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies
Ann Rheum Dis, May 1, 2001; 60(5): 433 - 441.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Naora, Y. Yang, F. J. Montz, J. D. Seidman, R. J. Kurman, and R. B. S. Roden
A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells
PNAS, March 27, 2001; 98(7): 4060 - 4065.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Jager, S. Gnjatic, Y. Nagata, E. Stockert, D. Jager, J. Karbach, A. Neumann, J. Rieckenberg, Y.-T. Chen, G. Ritter, et al.
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
PNAS, October 24, 2000; 97(22): 12198 - 12203.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.